Helena Rodbard is an Endocrinologist in Rockville, Maryland. Dr. Rodbard is rated as an Elite provider by MediFind in the treatment of Type 2 Diabetes (T2D). Her top areas of expertise are Type 2 Diabetes (T2D), Low Blood Sugar, Maturity Onset Diabetes of the Young, and Type 1 Diabetes (T1D).

Rozalina Mccoy is an Endocrinologist in Baltimore, Maryland. Dr. Mccoy has been practicing medicine for over 17 years and is rated as an Elite provider by MediFind in the treatment of Type 2 Diabetes (T2D). Her top areas of expertise are Low Blood Sugar, Type 2 Diabetes (T2D), Maturity Onset Diabetes of the Young, and Diabetic Hyperglycemic Hyperosmolar Syndrome.

Dr. Maruthur has a primary care practice at the Levine Group Internal Medicine Practice at Johns Hopkins Green Spring Station. In addition to seeing patients for one-half day per week, Dr. Maruthur conducts clinical research in diabetes with an emphasis on prevention. She is especially interested in community-based approaches to improving diabetes outcomes and individualized medicine, the tailoring of preventive and treatment strategies based on an individual's biology and preferences. Dr. Maruthur also directs the JHU General Internal Medicine Fellowship. This provider is registered with the Florida Department of Health to perform telehealth services for patients in Florida. Dr. Maruthur is rated as a Distinguished provider by MediFind in the treatment of Type 2 Diabetes (T2D). Her top areas of expertise are Type 2 Diabetes (T2D), Maturity Onset Diabetes of the Young, Low Blood Sugar, Obesity, and Gastric Bypass.

Justin Tcheugui is an Endocrinologist in Baltimore, Maryland. Dr. Tcheugui is rated as a Distinguished provider by MediFind in the treatment of Type 2 Diabetes (T2D). His top areas of expertise are Type 2 Diabetes (T2D), Maturity Onset Diabetes of the Young, Type 1 Diabetes (T1D), and Gestational Diabetes.

Dr. Mathioudakis, an endocrinologist and researcher, has a strong focus on diabetes management and patient care, recognized through awards like the Baltimore Top Doc. He has contributed significantly to diabetes research, authoring over 150 publications and participating in the development of consensus guidelines in the field. His studies have offered valuable insights into using health informatics for diabetes prevention and management. After graduating from the Johns Hopkins University School of Medicine and completing his training in Internal Medicine and a fellowship in Endocrinology, Diabetes, & Metabolism, Dr. Mathioudakis joined the faculty in the Division of Endocrinology, Diabetes & Metabolism in 2012. He earned a Master of Health Science in clinical investigation in 2015 and was the Clinical Director of the Division of Endocrinology from 2016 to 2021. Currently, he co-directs the Baltimore Metropolitan Diabetes Regional Partnership, focusing on improving access to diabetes prevention and management programs. As a physician-scientist, Dr. Mathioudakis leads multiple research studies funded by the NIH, private philanthropic organizations (Helmsley Charitable Trust), non-profit organizations (Breakthrough T1D), and industry. His research focuses on the effectiveness of automated diabetes prevention programs and strategies to reduce racial disparities in diabetes technology access. He also collaborates nationally to enhance care for people with type 1 diabetes. Holding a joint appointment in the Division of Biomedical Informatics and Data Science, Dr. Mathioudakis integrates machine learning and AI in diabetes research. He has served on the national Epic Endocrinology Specialty Steering Board and chaired the Type 2 Diabetes Prognostics Working Group for the Precision Medicine Diabetes Initiative. Committed to education, he frequently lectures on endocrinology, epidemiology, and health informatics. Dr. Mathioudakis is rated as a Distinguished provider by MediFind in the treatment of Type 2 Diabetes (T2D). His top areas of expertise are Type 2 Diabetes (T2D), Type 1 Diabetes (T1D), Low Blood Sugar, Maturity Onset Diabetes of the Young, and Pancreaticoduodenectomy.

Dr. Scott Pilla earned his M.D. at Robert Wood Johnson Medical School and completed his residency at Johns Hopkins Bayview Medical Center. He completed the Johns Hopkins General Internal Medicine Fellowship in clinical research in 2018. Dr. Pilla is rated as a Distinguished provider by MediFind in the treatment of Type 2 Diabetes (T2D). His top areas of expertise are Low Blood Sugar, Type 2 Diabetes (T2D), Maturity Onset Diabetes of the Young, and Obesity.

Sherita Golden is an Endocrinologist in Baltimore, Maryland. Dr. Golden is rated as a Distinguished provider by MediFind in the treatment of Type 2 Diabetes (T2D). Her top areas of expertise are Type 1 Diabetes (T1D), Type 2 Diabetes (T2D), Maturity Onset Diabetes of the Young, Obesity, and Hormone Replacement Therapy (HRT).

Dr. Sudipa Sarkar is an assistant professor of medicine at the Johns Hopkins University School of Medicine. Her areas of clinical expertise include endocrinology. She received her M.D. from Yale School of Medicine. She completed her residency in internal medicine at Yale-New Haven Hospital and performed a fellowship in endocrinology, diabetes and metabolism at Vanderbilt University Medical Center. Dr. Sarkar joined the Johns Hopkins faculty in 2017. Dr. Sarkar is rated as a Distinguished provider by MediFind in the treatment of Type 2 Diabetes (T2D). Her top areas of expertise are Type 2 Diabetes (T2D), Diabetic Retinopathy, Maturity Onset Diabetes of the Young, Diabetic Neuropathy, and Sleeve Gastrectomy.

Vikram Shenoy, M.D., practices endocrinology at Johns Hopkins Community Physicians Downtown Bethesda. He received his medical degree from University of Connecticut School of Medicine, and also completed his residency in endocrinology at Hospital of the University of Pennsylvania. He practices general endocrinology, including the treatment of thyroid disorders, diabetes, PCOS, pituitary and adrenal disorders, hypogonadism and osteoporosis. Dr. Shenoy is rated as a Distinguished provider by MediFind in the treatment of Type 2 Diabetes (T2D). His top areas of expertise are Type 2 Diabetes (T2D), Maturity Onset Diabetes of the Young, Type 1 Diabetes (T1D), and Hypothyroidism.

Sunil Gupta is a primary care provider, practicing in Internal Medicine in Cumberland, Maryland. Dr. Gupta is rated as a Distinguished provider by MediFind in the treatment of Type 2 Diabetes (T2D). His top areas of expertise are Hypertension, Familial Hypertension, Glucocorticoid-Remediable Aldosteronism, Craniectomy, and Extracranial-Intracranial Bypass Surgery. Dr. Gupta is currently accepting new patients.

Suresh Patel is a primary care provider, practicing in Internal Medicine in Waldorf, Maryland. Dr. Patel is rated as a Distinguished provider by MediFind in the treatment of Type 2 Diabetes (T2D). His top areas of expertise are Familial Hypertension, Hypertension, Glucocorticoid-Remediable Aldosteronism, and Multiple Carboxylase Deficiency.

Kashif Munir is an Endocrinologist in Baltimore, Maryland. Dr. Munir is rated as a Distinguished provider by MediFind in the treatment of Type 2 Diabetes (T2D). His top areas of expertise are Type 2 Diabetes (T2D), Thyroid Cancer, Thyroid Storm, Pituitary Tumor, and Thyroidectomy.

Jonathan Rich is a primary care provider, practicing in Internal Medicine in Baltimore, Maryland. Dr. Rich is rated as a Distinguished provider by MediFind in the treatment of Type 2 Diabetes (T2D). His top areas of expertise are Heart Failure, Hypertension, Type 2 Diabetes (T2D), Heart Transplant, and Lung Transplant.

Dr. Rita Kalyani is a Professor of Medicine at Johns Hopkins School of Medicine. She graduated with an undergraduate degree from Harvard College and completed her medical degree, residency, and fellowship at Johns Hopkins. She also obtained a Masters in Health Science degree in Clinical Investigation from the Johns Hopkins Bloomberg School of Public Health. As a NIH-funded clinician scientist, Dr. Kalyani has authored over 175 peer-reviewed publications and built a research program focused on understanding the factors leading to development of diabetes complications, particularly in high-risk populations. She has conducted epidemiological and patient-oriented research that has led to fundamental discoveries regarding the development of skeletal muscle loss, physical disability, and frailty in diabetes. She has also spearheaded studies investigating sex differences in cardiovascular disease and diabetes which have influenced primary prevention guidelines. Dr. Kalyani launched the Diabetes Management Service for Johns Hopkins’ Total Pancreatectomy Islet Auto Transplant Program in 2011. She is the co-founder of the Johns Hopkins Diabetes POC-IT Guide for healthcare professionals. She is also the founder and past Editor-in-Chief of the Johns Hopkins Patient Website to Diabetes. Dr. Kalyani has been the Chief Scientific and Medical Officer of the American Diabetes Association since 2025. She previously served as President of Medicine & Science on the ADA's National Board of Directors. She continues to have a clinical practice as an adult endocrinologist. Dr. Kalyani is rated as an Advanced provider by MediFind in the treatment of Type 2 Diabetes (T2D). Her top areas of expertise are Seasonal Affective Disorder (SAD), Type 2 Diabetes (T2D), Maturity Onset Diabetes of the Young, Pancreatectomy, and Islet Cell Transplantation.

Mark Corriere is an Endocrinologist in Towson, Maryland. Dr. Corriere is rated as an Advanced provider by MediFind in the treatment of Type 2 Diabetes (T2D). His top areas of expertise are Type 2 Diabetes (T2D), Type 1 Diabetes (T1D), Thyroid Nodule, and Hypothyroidism.

Dr. Donner's clinical and research interests have focused on the prevention of complications in patients with type 1 and 2 diabetes. For 6 years, he was the Associate Medical Director of the Joslin Diabetes Center affiliate at the University of Maryland, and then Medical Director from 2004 - 2010. After joining the faculty at Johns Hopkins University in 2010, his clinical and research interests became fully dedicated to diabetes. He became the Director of The Johns Hopkins Diabetes Center in 2011. He has been a clinical investigator in a number of NIH- and industry-funded diabetes research trials. Dr. Donner was a co-PI in the NIH-funded Veterans Affairs Implantable Insulin Pump Study, a Co-PI on the NIDDK-funded Diabetes Control and Complications Trial / Epidemiology of Diabetes Intervention and Complications (DCCT / EDIC) Study for 16 years, and Co-PI for the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) for 7 years. Recently, he has served as PI for the Durable-response therapy Evaluation For Early or New-onset type 1 Diabetes (DEFEND-1). Dr. Donner is currently collaborating with Dr. Abdel Hamad in Immunology on preventing B-regulatory cell apoptosis using a novel monoclonal antibody targeting the presumptive apoptotic factor. This antibody prevents the development of type 1 diabetes in non obese diabetic mice. Dr. Donner is the PI for Johns Hopkins for TrialNet, a multicenter, international consortium of investigators studying ways to prevent Type 1 diabetes and preserve insulin secretion in individuals with newly diagnosed Type 1 diabetes. He is also a PI for a study investigating FIAsp, a faster-acting insulin aspart in subjects with type 1 diabetes, and is working with investigators at the Johns Hopkins School of Engineering on an implantable insulin pump which delivers insulin intravenously. Dr. Donner is rated as an Advanced provider by MediFind in the treatment of Type 2 Diabetes (T2D). His top areas of expertise are Type 1 Diabetes (T1D), Diabetic Nephropathy, Type 2 Diabetes (T2D), and Maturity Onset Diabetes of the Young.

Jose Loveria, MD, specializes in internal medicine and is board-certified in internal medicine by the American Board of Internal Medicine. He practices at UPMC Primary Care at the Western Maryland Medical Arts Center. Dr. Loveria completed his medical degree at Far Eastern University - Nicanor Reyes Medical Foundation and residency at St. Barnabas - Medical Center. Dr. Loveria is rated as an Advanced provider by MediFind in the treatment of Type 2 Diabetes (T2D). His top areas of expertise are High Cholesterol, Cirrhosis, Familial Combined Hyperlipidemia, and Xanthoma.

Nicholas Argento, M.D. attended Georgetown University and graduated Magna Cum Laude with a BS in Biology, then the University of Maryland School of Medicine and graduated Cum Laude. He completed his residency in Internal Medicine and fellowship in Diabetes, Endocrine and Metabolism at the University of Maryland Medical System. He joined Maryland Endocrine full time in 1991. He has been the Medical Advisor to the diabetes program at Johns Hopkins Howard County Medical Center since 1995, and gives talks regularly to medical and patient audiences on diabetes. He has a strong interest in type 1 diabetes (T1D), and has extensive experience in utilizing insulin pumps and continuous glucose monitoring (CGM) to help patients safely achieve better blood glucose control. He has 4 publications in medical journals on different aspects of CGM use, and was co-author or contributor to multiple chapters in the 2013 American Diabetes Association book, Putting Your Patient On The Pump, 2nd edition. He has presented clinical research multiple times at the American Diabetes Association Scientific Sessions and other medical meetings, and has spoken to local, national, and international audiences on insulin pumps and the clinical application of CGM technology. He is very active on and lends medical support to and has written numerous articles for the T1DExchange website myglu.org, a website dedicated to outreach, research and engagement of and for the T1D community. For more information, visit marylandendocrine.com. Dr. Argento is rated as an Advanced provider by MediFind in the treatment of Type 2 Diabetes (T2D). His top areas of expertise are Type 1 Diabetes (T1D), Hypothyroidism, Type 2 Diabetes (T2D), and Vitamin D Deficiency.

Dr. Bennett practices all aspects of primary care medicine, including preventive care and coordiantion of care with other specialists. She has particular interests in weight management and women's health care. She sees patients at Johns Hopkins Bayview Medical Center. Dr. Bennett is an Assistant Professor in the Division of General Internal Medicine, with joint appointments at The Johns Hopkins University Bloomberg School of Public Health. Dr. Bennett is rated as an Advanced provider by MediFind in the treatment of Type 2 Diabetes (T2D). Her top areas of expertise are Obesity, Gestational Diabetes, Peripheral Artery Disease, and Type 2 Diabetes (T2D).

Scott Maurer is a primary care provider, practicing in Geriatrics in Glenwood, Maryland. Dr. Maurer is rated as an Advanced provider by MediFind in the treatment of Type 2 Diabetes (T2D). His top areas of expertise are Familial Combined Hyperlipidemia, Xanthoma, Cirrhosis, and High Cholesterol.